Metriport

About Metriport

Metriport is a healthcare technology firm providing an open-source interoperability platform designed to streamline access to patient medical data for healthcare organizations. Founded in 2021 by software engineers Dima Goncharov (CEO) and Colin Elsinga (COO), the San Francisco-based company aims to create a unified 'internet for healthcare data'. The founders, friends for over 15 years, both left their software engineering jobs to start the company, initially developing a consumer health tracking app. This early work and their acceptance into Y Combinator's Summer 2022 batch revealed the significant challenge of accessing fragmented medical data, leading them to pivot to a business-to-business model.

The company's core offering is a universal API that integrates with major health information networks like CommonWell and Carequality, as well as EHRs, pharmacies, and labs. This allows digital health companies, ambulatory practices, and hospital systems to retrieve comprehensive patient records—including histories, medications, lab results, and allergies—in seconds using a single connector. Metriport's platform addresses the cumbersome and time-consuming manual process of data retrieval, which often relies on faxes and phone calls, by automating access and consolidating records from disparate sources. The service is particularly beneficial for telehealth providers who manage patients across different regions. Revenue is generated based on a sliding scale pricing structure that considers patient volume and the type of data required.

Metriport's key differentiator is its open-source foundation, which provides transparency and allows customers to avoid vendor lock-in by hosting the code on their own servers. The platform standardizes, de-duplicates, and consolidates the retrieved information into standardized formats like FHIR R4 and offers AI-powered clinical summaries. In addition to its Medical API, Metriport provides a no-code provider dashboard for managing patient records and developer tools to facilitate integration. After graduating from Y Combinator, the company secured $2.4 million in a seed funding round in December 2022, achieving a $20 million valuation. This capital has supported team growth and accelerated product development, leading to the public launch of its flagship Medical API and Dashboard in September 2023.